What is the catalog number for SIRT1 Rabbit Polyclonal Antibody?

The catalog number for SIRT1 Rabbit Polyclonal Antibody is orb215913.

What sizes are available for SIRT1 Rabbit Polyclonal Antibody?

SIRT1 Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is SIRT1 Rabbit Polyclonal Antibody in stock?

SIRT1 Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

SIRT1 Rabbit Polyclonal Antibody

Anti-SIRT1 Antibody. Tested in IF, ICC, WB applications. This antibody reacts with Human.

Product Specifications

Product Name Alternative

NAD-dependent protein deacetylase sirtuin-1; hSIRT1; 3.5.1.-; Regulatory protein SIR2 homolog 1; SIR2-like protein 1; hSIR2; SirtT1 75 kDa fragment; 75SirT1; SIRT1; SIR2L1

UniProt

Q96EB6

Reactivity

Human

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

E.coli-derived human SIRT1 recombinant protein (Position: R112-K311) . Human SIRT1 shares 90% amino acid (aa) sequence identity with mouse SIRT1.

Target

NAD-dependent protein deacetylase sirtuin-1

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Cancer Biology, Cell Biology, Disease Biomarkers, Metabolism Research

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Western blot, 0.1-0.5μg/ml, Human Immunocytochemistry/Immunofluorescence, 5 μg/ml, Human

Form

Lyophilized

Molecular Weight

120 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

ICC, IF, WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.